chr21-26170776-C-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000357903.7(APP):​c.-156G>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00706 in 784,406 control chromosomes in the GnomAD database, including 115 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0082 ( 31 hom., cov: 33)
Exomes 𝑓: 0.0068 ( 84 hom. )

Consequence

APP
ENST00000357903.7 5_prime_UTR

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -2.21

Publications

4 publications found
Variant links:
Genes affected
APP (HGNC:620): (amyloid beta precursor protein) This gene encodes a cell surface receptor and transmembrane precursor protein that is cleaved by secretases to form a number of peptides. Some of these peptides are secreted and can bind to the acetyltransferase complex APBB1/TIP60 to promote transcriptional activation, while others form the protein basis of the amyloid plaques found in the brains of patients with Alzheimer disease. In addition, two of the peptides are antimicrobial peptides, having been shown to have bacteriocidal and antifungal activities. Mutations in this gene have been implicated in autosomal dominant Alzheimer disease and cerebroarterial amyloidosis (cerebral amyloid angiopathy). Multiple transcript variants encoding several different isoforms have been found for this gene. [provided by RefSeq, Aug 2014]
APP-DT (HGNC:55075): (APP divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 21-26170776-C-G is Benign according to our data. Variant chr21-26170776-C-G is described in ClinVar as Likely_benign. ClinVar VariationId is 339655.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0638 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
APPNM_000484.4 linkc.-156G>C upstream_gene_variant ENST00000346798.8 NP_000475.1 P05067-1A0A140VJC8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
APPENST00000346798.8 linkc.-156G>C upstream_gene_variant 1 NM_000484.4 ENSP00000284981.4 P05067-1

Frequencies

GnomAD3 genomes
AF:
0.00826
AC:
1256
AN:
152060
Hom.:
31
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00179
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0263
Gnomad ASJ
AF:
0.00231
Gnomad EAS
AF:
0.0701
Gnomad SAS
AF:
0.00579
Gnomad FIN
AF:
0.0181
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00265
Gnomad OTH
AF:
0.00479
GnomAD4 exome
AF:
0.00678
AC:
4286
AN:
632238
Hom.:
84
Cov.:
9
AF XY:
0.00666
AC XY:
2140
AN XY:
321166
show subpopulations
African (AFR)
AF:
0.00122
AC:
15
AN:
12284
American (AMR)
AF:
0.0326
AC:
282
AN:
8654
Ashkenazi Jewish (ASJ)
AF:
0.00184
AC:
24
AN:
13034
East Asian (EAS)
AF:
0.0717
AC:
1755
AN:
24470
South Asian (SAS)
AF:
0.00510
AC:
204
AN:
39962
European-Finnish (FIN)
AF:
0.0174
AC:
504
AN:
28900
Middle Eastern (MID)
AF:
0.00175
AC:
4
AN:
2286
European-Non Finnish (NFE)
AF:
0.00273
AC:
1289
AN:
471990
Other (OTH)
AF:
0.00682
AC:
209
AN:
30658
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
213
426
638
851
1064
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00820
AC:
1248
AN:
152168
Hom.:
31
Cov.:
33
AF XY:
0.00957
AC XY:
712
AN XY:
74398
show subpopulations
African (AFR)
AF:
0.00178
AC:
74
AN:
41528
American (AMR)
AF:
0.0260
AC:
398
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00231
AC:
8
AN:
3470
East Asian (EAS)
AF:
0.0697
AC:
360
AN:
5166
South Asian (SAS)
AF:
0.00559
AC:
27
AN:
4828
European-Finnish (FIN)
AF:
0.0181
AC:
192
AN:
10600
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00265
AC:
180
AN:
67968
Other (OTH)
AF:
0.00427
AC:
9
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
58
116
174
232
290
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00482
Hom.:
1
Bravo
AF:
0.00996
Asia WGS
AF:
0.0330
AC:
113
AN:
3460

ClinVar

Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Mar 24, 2019
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

See Variant Classification Assertion Criteria. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Early-onset autosomal dominant Alzheimer disease Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.044
DANN
Benign
0.67
PhyloP100
-2.2
PromoterAI
0.059
Neutral
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs45476095; hg19: chr21-27543094; API